Release Date: 23/06/09 18:09 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 93.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%